(DBAN) Deutsche Beteiligungs - Ratings and Ratios
Private Equity, Venture Capital, Fund Investments, Expansion Capital, Management Buyout
DBAN EPS (Earnings per Share)
DBAN Revenue
Description: DBAN Deutsche Beteiligungs
Deutsche Beteiligungs AG is a private equity and venture capital firm that specializes in direct and fund of fund investments, focusing on various industries such as materials, industrials, and technology. The firms investment strategy includes expansion capital, management buyout, and growth capital, targeting small and medium-sized companies, particularly in Germany, Austria, and Switzerland.
From a financial perspective, Deutsche Beteiligungs AG has a market capitalization of approximately €455.93 million, with a price-to-earnings ratio of 9.96, indicating a relatively undervalued stock. The return on equity (RoE) stands at 9.34%, suggesting a decent profitability. To further evaluate the companys performance, we can examine additional key performance indicators (KPIs) such as the dividend yield, which is not provided. However, we can infer that the companys ability to generate cash and distribute dividends is crucial. A review of the companys historical dividend payments and the dividend payout ratio would provide valuable insights.
Deutsche Beteiligungs AGs investment preferences, including a focus on mid-market companies and a specific investment size range (€10 million to €200 million), suggest a targeted approach. The firms expertise in various industries and its geographical focus on Europe, particularly the DACH region, may provide a competitive edge. To assess the companys growth prospects, we can analyze its investment portfolios performance, including the number of successful exits, the average return on investment, and the overall portfolio valuation. These metrics can help investors understand the firms ability to generate returns and create value.
To gain a deeper understanding of Deutsche Beteiligungs AGs stock performance, we can examine the technical data. Although the current price is €25.70, the stock has shown a relatively stable trend, with a 20-day simple moving average (SMA) of €24.69 and a 50-day SMA of €25.31. The average true range (ATR) is €0.65, indicating a moderate level of volatility. Further analysis of the stocks trading volume, order book, and short interest could provide additional insights into market sentiment and potential price movements.
Additional Sources for DBAN Stock
DBAN Stock Overview
Market Cap in USD | 560m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception |
DBAN Stock Ratings
Growth Rating | -11.5 |
Fundamental | 7.98 |
Dividend Rating | 11.6 |
Rel. Strength | -21.9 |
Analysts | - |
Fair Price Momentum | 22.78 EUR |
Fair Price DCF | 17.34 EUR |
DBAN Dividends
Dividend Yield 12m | 1.00% |
Yield on Cost 5y | 0.97% |
Annual Growth 5y | -4.04% |
Payout Consistency | 66.8% |
Payout Ratio | 15.2% |
DBAN Growth Ratios
Growth Correlation 3m | 26.4% |
Growth Correlation 12m | 19.1% |
Growth Correlation 5y | -48% |
CAGR 5y | -0.30% |
CAGR/Max DD 5y | -0.01 |
Sharpe Ratio 12m | -0.15 |
Alpha | -10.70 |
Beta | 0.757 |
Volatility | 22.57% |
Current Volume | 8.2k |
Average Volume 20d | 7.9k |
As of July 07, 2025, the stock is trading at EUR 25.50 with a total of 8,151 shares traded.
Over the past week, the price has changed by +1.37%, over one month by +3.19%, over three months by +17.49% and over the past year by +1.52%.
Neither. Based on ValueRay´s Fundamental Analyses, Deutsche Beteiligungs is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 7.98 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DBAN is around 22.78 EUR . This means that DBAN is currently overvalued and has a potential downside of -10.67%.
Deutsche Beteiligungs has no consensus analysts rating.
According to our own proprietary Forecast Model, DBAN Deutsche Beteiligungs will be worth about 25.7 in July 2026. The stock is currently trading at 25.50. This means that the stock has a potential upside of +0.86%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 41.9 | 64.3% |
Analysts Target Price | - | - |
ValueRay Target Price | 25.7 | 0.9% |